Advances in MRI for the diagnosis of multiple sclerosis: A focus on radiological markers

MS Academy will host a live webinar on Monday, 8th December at 16:00. You are invited to watch the webinar from your computer or tablet. We will be live for 1 hour and 50 minutes via Zoom and a recording of the MS Academy session will be available following the meeting.

16:00 - 17:00 MS Academy webinar:
Advances in MRI for the diagnosis of multiple sclerosis: A focus on radiological markers

17:00 - 17:05 Break

17:05 - 17:50 Novartis non-promotional satellite symposium:
Unmasking Silent MS Progression: Why Early High-Efficacy Treatment Matters

MS Academy webinar:
Advances in MRI for the diagnosis of multiple sclerosis: A focus on radiological markers

This webinar is designed for healthcare professionals who want to deepen their understanding of advanced MRI markers in the diagnosis of multiple sclerosis (MS). The session will provide a detailed update on the latest MS diagnostic criteria, with particular emphasis on neuroradiological features that support accurate and timely diagnosis.

Participants will learn the clinical significance of two key imaging markers: paramagnetic rim lesions and the central vein sign.

Speakers will guide attendees through how these features can be identified on MRI scans, and how they contribute to distinguishing MS from other neurological conditions.

The webinar will include real-world imaging examples, practical guidance, and time for audience questions, ensuring participants come away with knowledge directly applicable to their clinical practice.

Objectives:

• Learn about new diagnostic criteria for MS, particularly with relevance to neuroradiology
• Learn about the meaning of lesions with central vein and how to identify these on MRI scans.
• Learn about the meaning of paramagnetic rim lesions and how to identify these with MRI scans.
• Learn how to implement, interpret and report on the CVS and PRL in the diagnosis of MS

Novartis non-promotional satellite symposium:
Unmasking Silent MS Progression: Why Early High-Efficacy Treatment Matters

Objectives

• Learn about the hidden, silent progression in MS and why ‘stable’ does not mean inactive disease.
  
• Learn about the benefits and rationale for starting high-efficacy therapies early even before clinical relapses.
  
• Learn about advanced monitoring strategies to detect disease activity that standard MRI may miss.
  
• Learn about practical steps to identify and manage patients with ongoing silent disease activity making proactive treatment decisions

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

UK I November 2025 I FA - 11562419

The contents on this events page has been created and funded by Novartis.

This event is free to attend as a result of sponsorship from our sponsors. The current event sponsors are listed on this page. In the interest of Neurology Academy and our sponsors’ legitimate business interests, we make available your name, job title and workplace to our sponsors. It allows us to attract the most appropriate sponsors, delegates and speakers for the events and to facilitate potential collaboration and communication between you and the sponsors; and allows us to offer other relevant events and services to the healthcare and life science industries. You can ask us not to share your name, job title and workplace by emailing info@neurologyacademy.org. We respect the privacy of every person for whom we have personal data. The group privacy and cookies policy can be viewed here.